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Purpose: To report a case of a pediatric patient diagnosed with conjunctival lymphoma associated with
oral carbamazepine use.
Observation: An 11-year-old boy who presented with 5-month history of a small nasal conjunctival mass
in the left eye that failed therapy with topical corticosteroids. Upon excision and molecular analysis,
diagnosis of Follicular Lymphoma was favored. The patient was healthy and did not have any known risk
factors except for a history of epilepsy treated with systemic carbamazepine.
Conclusion and importance: We report a case of a rare childhood conjunctival lymphoma. Conjunctival
lymphomas may masquerade as chronic conjunctivitis, or scleritis that fail therapy with topical corti-
costeroids. Furthermore, our patient did not have any known risk factors such as old age, systemic
lymphoma or immunosuppression. The patient did have a history long-term use of systemic carba-
mazepine. This is to our knowledge the ﬁrst case conjunctival lymphoma that may be associated to the
use of carbamazepine.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
This case presents a rare diagnosis in a pediatric patient with a
possible link to a systemic medication. Overall, 97% of conjunctival
masses in children are benign and only 3% are malignant.1 The
differential diagnosis ranges from common cysts to reactive
lymphoid hyperplasia (RLH) to malignant tumors such as lym-
phoma. Our patient, a healthy 11-year-old male presented with a
conjunctival mass that failed to resolve with topical corticosteroid
use. Upon excision and molecular analysis, diagnosis of Follicular
Lymphoma was favored. In the absence of risk factors, history of
ocular diseases, and absence of systemic lymphoma, we turned to
the systemic use of carbamazepine for a possible link.2. Case report
The patient provided written consent for publication of personal
information including medical record details and photographs.ology, Kresge Eye Institute/
ntoine st., Detroit, MI 48201,
Torres).
Inc. This is an open access article uAn 11-year-old boy referred to our Eye Clinic with a 5-month
history of a small nasal conjunctival mass of the left eye. The
mass had failed to resolve despite topical corticosteroid drops. He
was otherwise healthy, with only a history of epilepsy treated with
carbamazepine 200 mg in the morning and 300 mg in the after-
noon for four years without any complications. He had no ocular
history and no known allergies. On ophthalmological examination,
his visual acuity was 20/20 (using Snellen chart) in each eye and the
eye examwas normal bilateral except for an elevated pinkish mass
in the conjunctiva of the left eye (Fig. 1A). Excisional biopsy was
performed under general anesthesia. The lesion excised was an
irregular fragment of tan gray mucosal soft tissue appearance
measuring 0.8 0.6 0.3 cm. Histopathological examination of the
mass showed dense nodular lymphoid inﬁltrate composed of a
mixture of small lymphocytes with irregular nuclear contours and
large transformed lymphoid cells with multiple prominent nucleoli
(>15 per high power ﬁeld) (Fig. 2A and B). Increased numbers of
tingible body macrophages were noted in these areas. Immuno-
peroxidase studies showed increased number of CD20 (Fig. 2C)
positive, Paired Box-5 positive B cells that were CD10 positive, B-
cell lymphoma (BCL) 6 positive and BCL 2 negative. Ki-67 immu-
nostain showed an abnormal pattern of staining in these nodules
and a proliferation index of 30%. T cells were morphologicallynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A. The left eye prior to surgical resection. Note the pink nasal conjunctival mass. B. The left eye two years after surgical resection and radiotherapy. The patient has remained
disease free.
Fig. 2. A. Microphotograph of the conjunctival biopsy specimen showing showed dense nodular lymphoid inﬁltrate (hematoxylin-eosin, magniﬁcation 40) B. The dense nodular
lymphoid inﬁltrates are composed of a mixture of small lymphocytes with irregular nuclear contours and large transformed lymphoid cells with multiple prominent nucleoli.
Increased numbers of tangible body macrophages are noted in these areas (hematoxylin-eosin, magniﬁcation 400) C. Immunoperoxidase studies showed increased number of
CD20 positive.
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hybridization for Mucosa-associated lymphoid tissue lymphoma
translocation 1 rearrangement was negative and Polymerase chain
reaction analysis for Immunoglobulin Heavy Chain (IgH) Gene
Rearrangement was positive. Which is consistent with a clonal B-
cell population. These results were compatible with a lymphopro-
liferative disorder with involvement of B-cell lymphoma and a
diagnosis of a Follicular Lymphoma was favored. The case was
consulted with Dr. Elaine S. Jaffe (Center for Cancer Research, Na-
tional Institute of Health) who agreed with diagnosis. Cerebrospi-
nal analysis, bone marrow biopsy and total body position emission
computerized tomography all were negative. He was treated with
two cycles of radiotherapy of 1.5 Gy each for a total dose of 30 Gy.
Two years after treatment, the patient’s visual acuity was 20/20 and
with no signs of lymphoproliferative disease (Fig. 1B).3. Discussion
Carbamazepine is commonly used as an anti-epileptic medica-
tion. The use of this medication has been associated with the
development of atypical lymphoid proliferation, cutaneous pseu-
dolymphoma syndrome and lymphoproliferative disorders.2
Interestingly, this drug and its main metabolite are excreted into
tears in clinically signiﬁcant amounts after oral intake.3 The pres-
ence of carbamazepine in tears exposes the ocular surface to un-
known phototoxic effects.4 Review of available literature showed
one case by Doughty et al. of a healthy 22-year-old male with
conjunctival metaplasia associated with oral carbamazepine use.The patient was symptom free and did not have any known risk
factors for conjunctival metaplasia such as dry eye disease, contact
lens wear or smoking. Further search of the literature shows an
association of carbamazepine use with the development of sys-
temic anaplastic large cell lymphoma.5 This case did not show ev-
idence of ocular involvement, yet it still highlights the possibility of
carbamazepine inducing the development of lymphoma.
Our case has characteristics consistent with benign RLH as well
as with follicular lymphoma. The histopathology examination
showed an inﬁltrate mass with plasma cells and tingible bodies,
both typically present in RLH. The presence of a clonal B-cell pop-
ulation favors the diagnosis of a lymphoma. In addition, the
immunoperoxidase studies for CD10 and CD20 were both positive,
which is characteristic but not exclusive of a follicular lymphoma.6
The mixed characteristics of the mass and the undetermined
role of carbamazepine in its origin provided a clinical challenge.
After discussing the beneﬁts and risks with the child’s family, a joint
decisionwas made to treat. The patient was treated with two cycles
of radiotherapy for a total dose of 30 Gy and has remained disease
free for two years. Furthermore, after a discussionwith the patient’s
neurologist, therapywas switched to lamotrigine 25mg twice a day
as alternative antiepileptic treatment. To our knowledge this is the
ﬁrst case report of a pediatric conjunctival lymphoma that may be
associated to carbamazepine use.Conﬂict of interest
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